Aldo J. Montaño‐Loza

机构：University of Alberta, University of Alberta Hospital · ORCID：0000-0002-2511-7980

发表论文 354 篇 · 总被引 16290 次 · h-index 58

代表论文

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 53)
• Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis (2025 · Journal of Hepatology · 被引 14)
• Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases (2025 · Liver International · 被引 14)
• Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 11)
• Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis (2025 · Journal of Hepatology · 被引 8)
• Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis (2025 · Alimentary Pharmacology & Therapeutics · 被引 7)